- Home
- AUPH vs BHC Comparison
AUPH vs BHC Comparison
Compare AUPH & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | BHC |
|---|---|---|
| Founded | 1993 | N/A |
| Country | Canada | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 2014 | 1996 |
Fundamental Metrics
Financial Performance| Metric | AUPH | BHC |
|---|---|---|
| Price | $14.93 | $6.84 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $17.25 | $8.00 |
| AVG Volume (30 Days) | 1.2M | ★ 2.6M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5075.00 | 423.08 |
| EPS | ★ 0.25 | N/A |
| Revenue | $283,055,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $17.54 | $4.61 |
| Revenue Next Year | $15.74 | N/A |
| P/E Ratio | $60.02 | ★ N/A |
| Revenue Growth | ★ 20.38 | N/A |
| 52 Week Low | $10.34 | $4.33 |
| 52 Week High | $19.25 | $8.69 |
Technical Indicators
Market Signals| Indicator | AUPH | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 37.04 | 78.78 |
| Support Level | $14.60 | $5.42 |
| Resistance Level | $15.23 | $7.26 |
| Average True Range (ATR) | 0.49 | 0.26 |
| MACD | -0.10 | 0.19 |
| Stochastic Oscillator | 17.08 | 98.03 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.